Merran S. Macpherson
Slough, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
A 4-week community-implemented diabetes prevention program is associated with improved metabolic outcomes at 12 months after participation.
Journal: Diabetic medicine : a journal of the British Diabetic Association
Published: January 20, 2026
Single-Injection Options for Administering a 320 mg Dose of Bimekizumab: 2 mL Safety Syringe and Auto-injector.
Journal: Dermatology and therapy
Published: December 22, 2024
Overview of preclinical and clinical studies investigating pharmacokinetics and drug-drug interactions of padsevonil.
Journal: Expert opinion on drug metabolism & toxicology
Published: June 27, 2024
Clinical Bridging Studies and Modeling Approach for Implementation of a Patient Centric Sampling Technique in Padsevonil Clinical Development.
Journal: The AAPS journal
Published: May 23, 2023
Dose selection for aztreonam-avibactam, including adjustments for renal impairment, for Phase IIa and Phase III evaluation.
Journal: European journal of clinical pharmacology
Published: December 22, 2022
Efficacy and safety of adjunctive padsevonil in adults with drug-resistant focal epilepsy: Results from two double-blind, randomized, placebo-controlled trials.
Journal: Epilepsia open
Published: May 26, 2022
A Pre-implementation Study of Volumetric Modulated Arc Therapy for Same-day Planning and Treatment of Vertebral Bone Metastases Within a Rapid-access Palliative Radiotherapy Programme.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: December 04, 2020
Cardiorespiratory fitness and accelerometer-determined physical activity following one year of free-living high-intensity interval training and moderate-intensity continuous training: a randomized trial.
Journal: The international journal of behavioral nutrition and physical activity
Published: July 26, 2019
Ceftazidime-Avibactam Population Pharmacokinetic Modeling and Pharmacodynamic Target Attainment Across Adult Indications and Patient Subgroups.
Journal: Clinical and translational science
Published: August 08, 2018
Population Pharmacokinetic Modelling of Ceftazidime and Avibactam in the Plasma and Epithelial Lining Fluid of Healthy Volunteers.
Journal: Drugs in R&D
Published: July 29, 2018
Comparing probability of target attainment against Staphylococcus aureus for ceftaroline fosamil, vancomycin, daptomycin, linezolid, and ceftriaxone in complicated skin and soft tissue infection using pharmacokinetic/pharmacodynamic models.
Journal: Diagnostic microbiology and infectious disease
Published: July 19, 2018
Ceftazidime-Avibactam Susceptibility Breakpoints against Enterobacteriaceae and Pseudomonas aeruginosa.
Journal: Antimicrobial agents and chemotherapy
Published: January 10, 2018
Last Updated: 09/26/2026